人口老龄化与医生协助死亡:州政府政策的演变

D. Orentlicher
{"title":"人口老龄化与医生协助死亡:州政府政策的演变","authors":"D. Orentlicher","doi":"10.18060/18390","DOIUrl":null,"url":null,"abstract":"As state governments respond to the needs of their aging populations, an issue of particular concern is health care at the end of life. With the many advances in public health and medical treatment — as well as in education, wealth, and other socioeconomic metrics — Americans are living much longer lives. But many Americans also face prolonged illness at the end of life that can result in great suffering. Often the suffering can be relieved with good palliative care, but for some Americans continued life becomes intolerable.As a result, there has been increased interest in a right for terminally ill individuals to hasten the dying process by taking a lethal dose of prescription medication (i.e., by “physician aid in dying,” commonly described as “physician-assisted suicide”). The existence of such a right has been litigated in the U. S. Supreme Court and state supreme courts, debated in state legislatures, and addressed in ballot proposals at the state level. Voters in Oregon and Washington have legalized aid in dying by public referendum, legislators in Vermont have done so by statutory enactment, and justices in Montana and a trial court in New Mexico have done so by court holding.In this Article, I discuss the trend toward legalization of physician aid in dying and what it tells us about societal morality regarding medical decisions at the end of life — while legal recognition of a right to aid in dying is growing, its greater recognition does not reflect a change in societal views about the propriety of physician-assisted suicide. We are not seeing an evolution in ethical thought. Rather, society is refining its legal rules for end-of-life law so they better reflect the public’s long-standing moral views about death-hastening choices at the end of life.","PeriodicalId":410798,"journal":{"name":"Medical-Legal Studies eJournal","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Aging Populations and Physician Aid in Dying: The Evolution of State Government Policy\",\"authors\":\"D. Orentlicher\",\"doi\":\"10.18060/18390\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As state governments respond to the needs of their aging populations, an issue of particular concern is health care at the end of life. With the many advances in public health and medical treatment — as well as in education, wealth, and other socioeconomic metrics — Americans are living much longer lives. But many Americans also face prolonged illness at the end of life that can result in great suffering. Often the suffering can be relieved with good palliative care, but for some Americans continued life becomes intolerable.As a result, there has been increased interest in a right for terminally ill individuals to hasten the dying process by taking a lethal dose of prescription medication (i.e., by “physician aid in dying,” commonly described as “physician-assisted suicide”). The existence of such a right has been litigated in the U. S. Supreme Court and state supreme courts, debated in state legislatures, and addressed in ballot proposals at the state level. Voters in Oregon and Washington have legalized aid in dying by public referendum, legislators in Vermont have done so by statutory enactment, and justices in Montana and a trial court in New Mexico have done so by court holding.In this Article, I discuss the trend toward legalization of physician aid in dying and what it tells us about societal morality regarding medical decisions at the end of life — while legal recognition of a right to aid in dying is growing, its greater recognition does not reflect a change in societal views about the propriety of physician-assisted suicide. We are not seeing an evolution in ethical thought. Rather, society is refining its legal rules for end-of-life law so they better reflect the public’s long-standing moral views about death-hastening choices at the end of life.\",\"PeriodicalId\":410798,\"journal\":{\"name\":\"Medical-Legal Studies eJournal\",\"volume\":\"23 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-11-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical-Legal Studies eJournal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18060/18390\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical-Legal Studies eJournal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18060/18390","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

随着各州政府对老龄人口的需求作出反应,一个特别令人关注的问题是生命末期的保健。随着公共卫生和医疗的进步,以及教育、财富和其他社会经济指标的进步,美国人的寿命更长了。但许多美国人在生命的最后时刻也面临着长期的疾病,这可能会导致巨大的痛苦。通常,通过良好的姑息治疗,这种痛苦可以得到缓解,但对一些美国人来说,继续生活变得无法忍受。因此,人们越来越关注身患绝症的人是否有权通过服用致命剂量的处方药(即“医生协助死亡”,通常被描述为“医生协助自杀”)来加速死亡过程。这种权利的存在已经在美国最高法院和州最高法院提起诉讼,在州立法机关进行辩论,并在州一级的投票提案中得到解决。俄勒冈州和华盛顿州的选民已经通过全民公决将协助死亡合法化,佛蒙特州的立法者已经通过制定法律来实现这一目标,蒙大拿州的法官和新墨西哥州的一个初审法院已经通过法院裁决实现了这一目标。在这篇文章中,我讨论了医生协助死亡合法化的趋势,以及它告诉我们的关于生命结束时医疗决定的社会道德——虽然法律承认帮助死亡的权利正在增长,但它的更大认可并没有反映出社会对医生协助自杀的适当性的看法的变化。我们没有看到伦理思想的进化。相反,社会正在完善其生命终结法的法律规则,以便更好地反映公众长期以来对生命终结时加速死亡选择的道德观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Aging Populations and Physician Aid in Dying: The Evolution of State Government Policy
As state governments respond to the needs of their aging populations, an issue of particular concern is health care at the end of life. With the many advances in public health and medical treatment — as well as in education, wealth, and other socioeconomic metrics — Americans are living much longer lives. But many Americans also face prolonged illness at the end of life that can result in great suffering. Often the suffering can be relieved with good palliative care, but for some Americans continued life becomes intolerable.As a result, there has been increased interest in a right for terminally ill individuals to hasten the dying process by taking a lethal dose of prescription medication (i.e., by “physician aid in dying,” commonly described as “physician-assisted suicide”). The existence of such a right has been litigated in the U. S. Supreme Court and state supreme courts, debated in state legislatures, and addressed in ballot proposals at the state level. Voters in Oregon and Washington have legalized aid in dying by public referendum, legislators in Vermont have done so by statutory enactment, and justices in Montana and a trial court in New Mexico have done so by court holding.In this Article, I discuss the trend toward legalization of physician aid in dying and what it tells us about societal morality regarding medical decisions at the end of life — while legal recognition of a right to aid in dying is growing, its greater recognition does not reflect a change in societal views about the propriety of physician-assisted suicide. We are not seeing an evolution in ethical thought. Rather, society is refining its legal rules for end-of-life law so they better reflect the public’s long-standing moral views about death-hastening choices at the end of life.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Who Gets Medication-assisted Treatment for Opioid Use Disorder, and Does It Reduce Overdose Risk? Evidence from the Rhode Island All-payer Claims Database The Architecture Behind the Malpractice Concept Guidelines Tax Evasion and Illicit Cigarettes in California: Part I – Survey Evidence on Current Behavior Regulatory Exclusivity Revision: Working to Achieve Greater Innovation in Approved New Molecular Entities Leviathan in the Commons: Biomedical Data and the State
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1